SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-20-014775
Filing Date
2020-06-25
Accepted
2020-06-25 18:48:42
Documents
1
Period of Report
2020-06-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 3638
  Complete submission text file 0001140361-20-014775.txt   5155
Mailing Address C/O HOLLIS-EDEN PHARMACEUTICALS 4435 EASTGATE MALL STE.400 SAN DIEGO CA 92121
Business Address
BURGESS DANIEL D (Reporting) CIK: 0001239650 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36912 | Film No.: 20990479

Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Issuer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)